[3H]-8-OH-DPAT binding in the rat brain raphe area: involvement of 5-HT1Aand non-5-HT1Areceptors
- 1 July 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 130 (6), 1348-1352
- https://doi.org/10.1038/sj.bjp.0703426
Abstract
1. The 5-HT(1A) agonist 8-OH-DPAT has been shown to have additional 5-HT uptake inhibiting properties. The present work was undertaken to examine further the binding of [(3)H]-8-OH-DPAT in the raphe area of the rat brain, a region rich in 5-HT(1A) receptors and 5-HT uptake sites. 2. 5-HT inhibited [(3)H]-8-OH-DPAT binding in a biphasic manner (pK(i1): 8.82+/-0.01, pK(i2): 6.07+/-0.05, n=4) with the low affinity site representing 36+/-4% of the total population. A biphasic inhibition curve was found also with the 5-HT(1A) antagonist, WAY 100635 (pK(i1): 8.65+/-0.17, pK(i2): 4.26+/-0.38, n=3). In the presence of 1 microM WAY 100635 to mask 5-HT(1A) receptors, 5-HT inhibited [(3)H]-8-OH-DPAT binding in a monophasic manner (pK(i): 6.04+/-0.07, n=3). 3. The affinities of various compounds for sites labelled by [(3)H]-8-OH-DPAT in the presence of 1 microM WAY 100635 and for sites labelled by [(3)H]-citalopram (a selective 5-HT uptake inhibitor) were determined. There was a significant correlation between pK(i) values at 5-HT uptake sites and at non-5HT(1A) sites labelled by [(3)H]-8-OH-DPAT (r=0.80, P<0. 001, n=17), suggesting these latter sites to be 5-HT uptake sites. 4. Whereas the affinities of R(+) and S(-) enantiomers of 8-OH-DPAT for the 5-HT uptake site are similar, R(+)8-OH-DPAT has 10 times higher affinity for the non-5-HT(1A) site than S(-)8-OH-DPAT and was considered as an outlier in the correlation. It is suggested that [(3)H]-8-OH-DPAT labels other, as yet unknown binding sites in the raphe.Keywords
This publication has 15 references indexed in Scilit:
- Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.1997
- Possible in vivo 5‐HT reuptake blocking properties of 8‐OH‐DPAT assessed by measuring hippocampal extracellular 5‐HT using microdialysis in ratsBritish Journal of Pharmacology, 1996
- Stereoselectivity of 8-OH-DPAT enantiomers at cloned human 5-HT1D receptor sitesEuropean Journal of Pharmacology, 1996
- A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635European Journal of Pharmacology, 1995
- Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.Proceedings of the National Academy of Sciences of the United States of America, 1993
- α2‐Adrenoceptor subtypes and imidazoline‐like binding sites in the rat brainBritish Journal of Pharmacology, 1990
- [3H]8-OH-DPAT labels the 5-Hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatumJournal of Pharmacy and Pharmacology, 1988
- [3H]8-OH-DPAT labels the serotonin transporter in the rat striatumEuropean Journal of Pharmacology, 1986
- Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brainEuropean Journal of Pharmacology, 1984
- Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PATNature, 1983